MoonLake Immunotherapeutics aksje
MLTX
Sanntid$17.93-0.89 (-4.73%)
Laster graf...
MoonLake Immunotherapeutics
Market Cap
$1,319,923,968
Åpning18.58
Høy18.58
Lav17.77
Volum474.89k
P/EN/A
Markedsverdi1.32B
52-ukers høy62.75
52-ukers lav5.95
Gj.sn. volum1M
UtbytteN/A
Beta1.01
EPS-3.88
Om MoonLake Immunotherapeutics aksje
MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
Selskapsinformasjon
Børs: NasdaqCM (NCM)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
Dorfstrasse 29
6300 Zug, Switzerland
6300 Zug, Switzerland
Telefon: + 41 415108022
Nettside: https://www.moonlaketx.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Anbefaling:1.87 - Køb
Laveste kursmål
6.00
↓ 66.5%
Gjennomsnittlig kursmål
27.62
↑ 54.0%
Median kursmål
30.00
↑ 67.3%
Høyeste kursmål
46.00
↑ 156.6%